Cardinal Health Closes Strive Medical Deal, Eyes AdaptHealth in H2 FY27
CAH sits 57% above its 52-week low of $145.87 on elevated volume (2.1× avg).
Summary
Cardinal Health has closed its acquisition of Strive Medical, adding at-home urology DME to its portfolio. The company also expects to close the AdaptHealth diabetes business deal in H2 FY2027, which will expand its continuous glucose monitoring presence. Fiscal 2026 saw double-digit earnings growth across all five segments, with FY27 guidance based on a more normalized growth base. This follows the July announcement of the $360 million cash deal for both assets. The completion of Strive and the clarified timeline for AdaptHealth provide concrete execution milestones for the company's expansion strategy.
At the time of this announcement, CAH was trading at $229.10 on NYSE in the Trade & Services sector, with a market capitalization of approximately $52.4B. The 52-week trading range was $145.87 to $258.30. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.